Selective Insurance Group, Inc. (NASDAQ: SIGI) has captured investor attention following a recent upgrade to an ‘Outperform’ rating by Michael Zaremski of BMO Capital on May 7, 2026. This upgrade comes with a price target of $97, which suggests a potential upside from its current trading price of $83. This favorable assessment presents a compelling opportunity for investors looking to capitalize on expected growth in the property and casualty insurance sector.
Recent Price Action
Over the past week, SIGI has shown some volatility, closing recently at $83. The stock moved up by $1.825, reflecting a robust gain of approximately 2.20%. As investors react to the new rating, trading volumes have also been noteworthy, with 237,083 shares changing hands compared to an average volume of 579,104. The company’s market capitalization stands at approximately $5.08 billion. Notably, SIGI’s stock has experienced a challenging year, trading significantly below its 52-week high of $93.27, a decrease of approximately 10.27%. Conversely, the stock’s low point over the past year was $16.78, underscoring its substantial recovery since hitting those depths.
Historical Performance
The performance of SIGI shares tells a complex story. Over the last 30 days, the stock has faced pressure with a monthly decline of 3.35%. In the last quarter, however, SIGI managed to just inch into positive territory with a growth of 0.25%. On a longer time frame, the stock has struggled over the past year, with a notable decline of 13.68%. Consistent volatility has characterized its trading behavior, evidenced by a 1.51% weekly volatility and 1.98% monthly volatility. Notably, in the last ten days, average volumes have slightly diminished to approximately 534,046, down from an average of about 551,124 over three months.
Earnings Analysis
Selective Insurance’s latest earnings report reveals a mixed picture. For the most recent quarter ending on April 22, 2026, the company delivered an earnings per share (EPS) of $1.69, falling short of the estimated EPS of $1.80 by 6.11%. This contrasts with the prior quarter (January 29, 2026), when SIGI significantly exceeded expectations with an EPS of $2.57 against an estimate of $2.02, yielding a notable surprise factor of 27.23%. This inconsistency raises questions about earnings predictability and underscores the challenges faced by the company in maintaining robust profitability amid market fluctuations.
Analyst Consensus View
Analysts appear to hold a generally favorable view of SIGI following the recent upgrade. The consensus rating over the past 90 days shows a split among four analysts, with two ratings as ‘Buy,’ two as ‘Hold,’ and no ‘Sell’ ratings. The average price target among analysts stands at $91, highlighting an optimistic outlook, while the individual price targets range from a conservative low of $84 to an enthusiastic high of $97. This range reflects both caution and potential optimism in the market regarding SIGI’s future performance.
Stock Grading and Fundamental View
Selective Insurance holds a Stocks Telegraph (ST) Score of 54, indicating a moderate potential for investment based on financial health and market dynamics. This rating suggests that while there are some underlying strengths in SIGI’s business operations, challenges persist that may hinder significant growth in the short term. Investors should closely monitor factors impacting the ST Score to understand their investment’s resilience.
Conclusion
For investors, Selective Insurance Group, Inc. (SIGI) exemplifies an intriguing opportunity, especially for those focused on long-term growth in the insurance sector. The recent upgrade to ‘Outperform’ suggests potential for upward price movement, making it suitable for growth-oriented investors. However, the stock’s mixed performance and recent earnings miss underscore a degree of risk, emphasizing the need for careful analysis. Investors should weigh these factors against their individual risk tolerance while keeping a close watch on SIGI’s upcoming earnings and market trends to navigate this investment landscape effectively.


